Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study (Q44961871)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study |
scientific article |
Statements
1 reference
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study (English)
1 reference
Susan M Blaney
1 reference
Martin A Champagne
1 reference
Renaud Capdeville
1 reference
Mark Krailo
1 reference
Wenchun Qu
1 reference
Bin Peng
1 reference
Marianne Rosamilia
1 reference
Martine Therrien
1 reference
Ulrike Zoellner
1 reference
Mark Bernstein
1 reference
Children's Oncology Group phase 1 study
1 reference
1 July 2004
1 reference
Identifiers
1 reference